Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Breast Neoplasms 536Neoplasms 432Carcinoma, Non-Small-Cell Lung 403Prostatic Neoplasms 334Colorectal Neoplasms 302Lung Neoplasms 262Multiple Myeloma 229Neoplasm Metastasis 186Leukemia, Myeloid, Acute 183Pancreatic Neoplasms 182Ovarian Neoplasms 166Melanoma 143Squamous Cell Carcinoma of Head and Neck 137Recurrence 114Carcinoma, Hepatocellular 113Carcinoma, Renal Cell 112Precursor Cell Lymphoblastic Leukemia-Lymphoma 111Stomach Neoplasms 109Lymphoma 109Head and Neck Neoplasms 108Endometrial Neoplasms 105Brain Neoplasms 104Lymphoma, Non-Hodgkin 102Glioblastoma 99Urinary Bladder Neoplasms 93Triple Negative Breast Neoplasms 92Uterine Cervical Neoplasms 89Hematologic Neoplasms 88Lymphoma, Large B-Cell, Diffuse 84Leukemia, Lymphocytic, Chronic, B-Cell 83

Interventions

tirbanibulin 1Cryotherapy 1BF-200 ALA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Keratosis, Actinic × 30 days × Clear all
NCT05662202 2026-05-22

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Biofrontera Inc.

Phase 3 Active not recruiting
172 enrolled
Dermatologic

Keratosis, Actinic

NCT07273656 2026-05-22

TIRBACRYO

University Hospital, Lille

Phase 3 Not yet recruiting
59 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

NCT05212246 2026-05-08

B3C

VA Office of Research and Development

Phase 3 Not yet recruiting
1,630 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Patient Compliance, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡